Back to search

Article

Has Noninvasive Prenatal Testing Impacted Termination of Pregnancy and Live Birth Rates of Infants With Down Syndrome?

2018-05-01

Abstract excerpt

(Abstracted from Prenat Diagn 2017;37:1281–1290) Noninvasive prenatal testing (NIPT) for aneuploidy using cell-free DNA (cfDNA) has become widely available and popular for detection of Down syndrome (DS) because of its high sensitivity (99%) and specificity (99.5%). The acceptance of NIPT as an alternative to the first-trimester combined test has greatly reduced the use of invasive prenatal diagnostic testing.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9d326961-ef12-558a-a458-5a89bce2bd2c
DOI
10.1097/01.ogx.0000534154.01991.cc
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Has Noninvasive Prenatal Testing Impacted Termination of Pregnancy and Live Birth Rates of Infants With Down Syndrome?DOI 10.1097/01.ogx.0000534154.01991.cc
Select a neighboring publication to make it the new centre.